919363-09-0

Basic information

• Product Name: 3-broMo-2-MethylbenzaMide
• Synonyms: 3-broMo-2-MethylbenzaMide;2-Methyl-3-broMobenzaMide
• CAS NO: 919363-09-0
• Molecular Formula: C₈H₈BrNO
• Molecular Weight: 214.05922
• Mol File: 919363-09-0.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 270.7±33.0 °C(Predicted)
• Appearance: /
• Density: 1.522±0.06 g/cm3(Predicted)
• PKA: 15.39±0.50(Predicted)
• CAS DataBase Reference: 3-broMo-2-MethylbenzaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-broMo-2-MethylbenzaMide(919363-09-0)
• EPA Substance Registry System: 3-broMo-2-MethylbenzaMide(919363-09-0)

Safety Data

• Hazardous Substances Data: 919363-09-0(Hazardous Substances Data)

Usage

General Description

3-bromo-2-methylbenzamide is a chemical compound with the molecular formula C8H8BrNO. It is an aromatic amide and specifically, a derivative of benzamide. 3-bromo-2-methylbenzamide is known for its diverse applications in the pharmaceutical and organic chemical industries. It is often used as a raw material in the synthesis of various pharmaceutical drugs and as a building block in organic synthesis. Its unique structure and properties make it valuable for the development of new drugs and materials. Additionally, 3-bromo-2-methylbenzamide is also used in research and development, particularly in the study of its reactivity and biological activity.

Upstream product

• 1177558-44-9 (3,5-dibromo-4-methylphenyl)amine hydrochloride 
• 101581-06-0 1,3-dibromo-2-methyl-5-nitrobenzene 
• 69321-60-4 2,6-dibromotoluene 
• 99-99-0 1-methyl-4-nitrobenzene 
• 21900-48-1 3-bromo-2-methylbenzoic acid chloride 
• 76006-33-2 3-bromo-2-methylbenzoic acid 
• 52780-15-1 3'-bromo-2'-methylbenzonitrile 

Downstream Products

• 2239273-34-6 3-(2-amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1,2,3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile 
• 35256-74-7 2-methyl-3-cyano-benzoyl chloride 
• 3843-99-0 2-methyl-3-cyano-benzoic acid 
• 1412438-71-1 3'-[(4-{[trans-4-(tert-butoxycarbonylamino-methyl)-cyclohexylmethyl]-amino}-5-nitro-pyrimidin-2-ylamino)-methyl]-2'-methyl-biphenyl-3-carboxylic acid 
• 1412438-40-4 propyl 3-[3-({[4-({[4-(aminomethyl)cyclohexyl]methyl}amino)-5-nitropyrimidin-2-yl]amino}methyl)-2-methylphenyl]benzoate 
• 1412438-68-6 ethyl 3-{3-[({5-cyano-4-[({4-[(tert-butoxycarbonylamino)methyl]cyclohexyl}methyl)amino]pyrimidin-2-yl}amino)methyl]-2-methylphenyl}benzoate 
• 1412438-59-5 ethyl 3-[3-(aminomethyl)-2-methylphenyl]-benzoate 
• 1412438-58-4 3'-[(4-{[trans-4-(tert-butoxycarbonylamino-methyl)-cyclohexylmethyl]-amino}-5-nitro-pyrimidin-2-ylamino)-methyl]-2'-methyl-biphenyl-3-carboxylic acid 
• 1236133-21-3 tert-butyl N-{[trans-4-{[(2-{[(3-bromo-2-methylphenyl)methyl]amino}-5-nitropyrimidin-4-yl)amino]methyl} cyclohexyl]methyl}carbamate 
• 1412438-57-3 2-(3-bromo-2-methyl-benzylamino)-4-thiocyanato-5-nitro pyrimidine 
• 943722-20-1 [(3-bromo-2-methylphenyl)methyl]amine hydrochloride 
• 1007580-28-0 4′-(1,3-dioxolan-2-yl)-3′-(trifluoromethyl)-1,1′-biphenyl-3-carboxamide 

Relevant articles and documents

Development of a Scalable and Practical Synthesis of AB928, a Dual A2a/A2bReceptor Antagonist

AB928 is a potent and selective dual antagonist of the A2a and A2b receptors, which is currently in clinical trials. Here, we report the development of two scalable and practical syntheses of AB928. The first-generation synthesis was used to successfully

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

NOVEL PKC INHIBITORS

The present invention relates to new kinase inhibitors, more specifically PKCθ inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular,